Filing Details
- Accession Number:
- 0001645627-17-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-02 10:56:02
- Reporting Period:
- 2017-04-27
- Filing Date:
- 2017-05-02
- Accepted Time:
- 2017-05-02 10:56:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 29,000 shares | Avg. Price: $0.09 | Total Value: $2,684.67 |
| Number of Shares After Transactions: | 20,508,449 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,480,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,481,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,482,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,483,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,484,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,485,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,486,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,487,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,488,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,489,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,490,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 700 | $0.10 | 20,491,149 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 300 | $0.10 | 20,491,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,492,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,493,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,494,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.10 | 20,495,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,496,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,497,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,498,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,499,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,500,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,501,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,502,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,503,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,504,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,505,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,506,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,507,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-28 | 1,000 | $0.09 | 20,508,449 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
